{
    "clinical_study": {
        "@rank": "63912", 
        "arm_group": {
            "arm_group_label": "Methacholine Chloride", 
            "arm_group_type": "Experimental", 
            "description": "children with bronchial asthma"
        }, 
        "brief_summary": {
            "textblock": "The Purpose of this study is to evaluate the safety and efficacy of SK-1211 inhalation\n      challenge in children with bronchial asthma."
        }, 
        "brief_title": "Study of Methacholine Chloride Inhalation Challenge in Children With Bronchial Asthma", 
        "condition": "Asthma", 
        "condition_browse": {
            "mesh_term": "Asthma"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Diagnosis of bronchial asthma\n\n          -  FEV1/FVC must be 70% or more\n\n          -  <10% decrease in FEV1 in response to inhalation of normal saline\n\n        Exclusion Criteria:\n\n          -  Moderate or severe airflow limitation\uff08FEV1<60% predicted\uff09\n\n          -  Heart attack or stroke in last 3 months\n\n          -  Uncontrolled hypertension, systolic BP>200, or diastolic BP>100\n\n          -  known aortic aneurysm"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "15 Years", 
            "minimum_age": "6 Years"
        }, 
        "firstreceived_date": "March 19, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02097537", 
            "org_study_id": "MC1002"
        }, 
        "intervention": {
            "arm_group_label": "Methacholine Chloride", 
            "intervention_name": "Methacholine Chloride (SK-1211)", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": "Methacholine Chloride"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "March 26, 2014", 
        "location": {
            "contact": {
                "email": "clinical@santen.co.jp", 
                "last_name": "Santen Pharmaceutical Co., Ltd.", 
                "phone": "+81-6-4802-9341"
            }, 
            "facility": {
                "address": {
                    "city": "Osaka", 
                    "country": "Japan"
                }, 
                "name": "Santen study sites"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Japan"
        }, 
        "official_title": "Study of Methacholine Chloride Inhalation Challenge in Children With Bronchial Asthma", 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Japan: Ministry of Health, Labor and Welfare"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "August 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "PC20 will be captured once at visit 1", 
            "measure": "The rate of subjects whose PC20, the concentration of methacholine that would provoke a fall in FEV1 of 20%, is less than 8mg/mL", 
            "time_frame": "Visit 1 (Day 1)"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02097537"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Santen Pharmaceutical Co., Ltd.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Santen Pharmaceutical Co., Ltd.", 
                "agency_class": "Industry"
            }
        }, 
        "study_design": "N/A", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}